Navigation Links
Pharmacogenomic Market Gaining Greater Acceptance Across Europe

stic tests remain major restraints for market growth. Lack of education and awareness among the medical community is an additional impediment, as physicians unfamiliar with this novel approach are more likely to abide by traditional methods. Eventually, patient demand could have the final say on the acceptance or rejection of pharmacogenomics.

"With clinical applicability being the prime competitive factor in the market, it will be crucial for pharmacogenomics developers to prove the clinical applicability of their tests to clinicians," says Dr. Rahman. "Clinical applicability includes the price of the test, clinical validity, specificity, sensitivity and prevalence of adverse conditions the test is seeking to prevent."

Going forward, companies will have to clearly demonstrate the clinical practicality of their tests to the medical community. Apart from oncologists, most physicians have misconceptions about the clinical practicality and do not understand the benefits of pharmacogenomic tests. Hence, they should be made aware of the long-term value proposition of pharmacogenomic testing in terms of lowering the overall healthcare cost and increasing patient well being.

European Personalised Medicine and Pharmacogenomics Market is part of the Drug Discovery Technologies Growth Partnership Service program, which also includes research on the following: European Molecular Diagnostics Markets, European IVD Market and European Cancer Diagnostic Market, European Primary Care Diagnostics. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants. Interviews with the press are available.

Frost & Sullivan, a global growth consulting company, has been partnering with clients to support the development of innovative strategies for more than 40 years. The company's industry expertise integrates growth cons
'"/>




Page: 1 2 3

Related medicine news :

1. Panacea Biotech To Market Anthrax Vaccine
2. Ranbaxy Labs Entry Into Anti-Acne Market
3. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
4. FDA To Set New Guidelines To Revise Drug Companies Marketing Tactics
5. Donated Mothers Milk To Hit The Market
6. New Four- in- one Vaccine For DTP & Hepatitis To Hit The Indian Market
7. Record Growth Of Soya-Based Dairy Alternatives Over The Past Year In European Markets
8. Junk Food Marketing to be banned
9. Biovac, Hepatitis A Vaccine Marketed By Wockhardt
10. Government Should Restrict Junk Food Marketing
11. Canada May Not Permit Bextra To Reenter Market
Post Your Comments:
(Date:8/1/2014)... -- Patients with the progressive, deadly respiratory ailment known ... weapon to battle the disease, the U.S. Food and ... a new treatment, an inhaled spray called Striverdi Respimat ... COPD, which is often linked to smoking, involves multiple ... Patients with COPD may experience a number of ...
(Date:8/1/2014)... -- Although many parents worry about their children choking on ... food. Such was the case for 15-month-old Landon ... handful of nuts. "At the time, Landon had a ... related to his illness or choking," recalled his mother, Ula ... become lodged in his windpipe and had to be removed ...
(Date:8/1/2014)... 2014 The North America Endpoint Security ... market in North America with analysis and forecast of ... $3.53 billion in 2014 to $4.77 billion by 2019, ... , Browse through the TOC of the North America ... the in-depth analysis provided. It also provides a glimpse ...
(Date:8/1/2014)... York, NY (PRWEB) August 01, 2014 ... Dentists industry have benefited from innovative technologies that ... that resemble a patient's tooth color. Moreover, the ... dentistry due to age-related tooth ailments. Due to ... decay, many elderly individuals have demanded dental fillings, ...
(Date:8/1/2014)... Scientists at Albert Einstein College of Medicine ... in digestion help keep the intestinal lining intact. The ... could yield new therapies for inflammatory bowel disease (IBD) ... research involved the intestinal microbiome, which contains some 100 ... or preventing disease is a major emerging field of ...
Breaking Medicine News(10 mins):Health News:FDA Approves New Treatment for People With COPD 2Health News:Food Is a Common Choking Hazard for Kids, Doctor Says 2Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 2Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 3Health News:North America End-Point Security Market is Expected to Reach $4 billion in 2019 - New Report by MicroMarket Monitor 4Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:'Normal' bacteria vital for keeping intestinal lining intact 2
... March 21 SRI International, an independent nonprofit research and development organization, will present preliminary results of a diagnostic to detect neglected tropical ... Francisco . , ... , , ... ...
... , March 21 "Tonight,s historic vote marks ... of the insurance industry and provide quality, affordable health care ... the determined leadership of President Barack Obama and ... necessary to defeat the special interests and do what is ...
... African American and white cancer patients are treated at ... equal. Published early online in Cancer , a ... suggest that where patients receive care may partly explain ... new study, researchers led by Tracy Onega, PhD, MA, ...
... A look ... you by the health coverage experts at the Center for Children and Families at Georgetown ... (PRWEB) March 22, ... Following Statement on Health Reform Passed by U.S. House of Representatives Today:, , ,The House ...
... , president and founder of the conservative grassroots public policy organization Eagle Forum, made the following remarks after the public announcement that formerly pro-life Democrat Bart Stupak ... ... , ... ...
... the House is expected to approve today, according to Congressman Chaka Fattah (D-PA-02). , ... , , ... ... "Small businesses ...
Cached Medicine News:Health News:SRI International Researchers to Present Work on Early Detection Tool for Neglected Tropical Diseases at 2010 American Chemical Society (ACS) Meeting 2Health News:SRI International Researchers to Present Work on Early Detection Tool for Neglected Tropical Diseases at 2010 American Chemical Society (ACS) Meeting 3Health News:SRI International Researchers to Present Work on Early Detection Tool for Neglected Tropical Diseases at 2010 American Chemical Society (ACS) Meeting 4Health News:SRI International Researchers to Present Work on Early Detection Tool for Neglected Tropical Diseases at 2010 American Chemical Society (ACS) Meeting 5Health News:SRI International Researchers to Present Work on Early Detection Tool for Neglected Tropical Diseases at 2010 American Chemical Society (ACS) Meeting 6Health News:'A Monumentally Important Victory for Our Country' 2Health News:Racial disparities diminish in specialized cancer centers 2Health News:Georgetown University Center for Children and Families Hails Health Reform As Big Win for Children and Families 2Health News:Schlafly: Health Care Vote Set to Expose the Myth of the 'Pro-Life Democrat' 2Health News:Schlafly: Health Care Vote Set to Expose the Myth of the 'Pro-Life Democrat' 3Health News:Rep. Fattah Says Small Businesses in Philadelphia Are Big Winners in Today's Healthcare Reform 2Health News:Rep. Fattah Says Small Businesses in Philadelphia Are Big Winners in Today's Healthcare Reform 3
(Date:7/31/2014)... MONROVIA, Calif., July 31, 2014 STAAR Surgical ... manufacturer and marketer of implantable lenses and delivery systems ... quarter ended July 4, 2014 of $20.0 million, a ... quarter of 2013. On a constant currency basis, revenues ... to the second quarter of 2013.  The effect of ...
(Date:7/31/2014)... Pharmacyclics, Inc. (the "Company") (Nasdaq: PCYC ) today ... June 30, 2014. Financial Results for the Six ... revenue for the quarter ended June 30, 2014 increased to ... 30, 2013 primarily due to IMBRUVICA ® (ibrutinib) net ... for the six months ended June 30, 2014 increased to ...
(Date:7/31/2014)... 2014  UBM Medica US announces that ... oncologists, presents exclusive slide shows dealing with communication in ... cancer care. Cancer Network, the ... news, blogs, and podcasts about the latest clinical findings. ... , End-of-life care is challenging for even ...
Breaking Medicine Technology:STAAR Surgical Reports 10% Second Quarter Revenue Growth 2STAAR Surgical Reports 10% Second Quarter Revenue Growth 3STAAR Surgical Reports 10% Second Quarter Revenue Growth 4STAAR Surgical Reports 10% Second Quarter Revenue Growth 5STAAR Surgical Reports 10% Second Quarter Revenue Growth 6STAAR Surgical Reports 10% Second Quarter Revenue Growth 7STAAR Surgical Reports 10% Second Quarter Revenue Growth 8STAAR Surgical Reports 10% Second Quarter Revenue Growth 9STAAR Surgical Reports 10% Second Quarter Revenue Growth 10STAAR Surgical Reports 10% Second Quarter Revenue Growth 11STAAR Surgical Reports 10% Second Quarter Revenue Growth 12STAAR Surgical Reports 10% Second Quarter Revenue Growth 13STAAR Surgical Reports 10% Second Quarter Revenue Growth 14STAAR Surgical Reports 10% Second Quarter Revenue Growth 15STAAR Surgical Reports 10% Second Quarter Revenue Growth 16STAAR Surgical Reports 10% Second Quarter Revenue Growth 17STAAR Surgical Reports 10% Second Quarter Revenue Growth 18STAAR Surgical Reports 10% Second Quarter Revenue Growth 19STAAR Surgical Reports 10% Second Quarter Revenue Growth 20STAAR Surgical Reports 10% Second Quarter Revenue Growth 21STAAR Surgical Reports 10% Second Quarter Revenue Growth 22STAAR Surgical Reports 10% Second Quarter Revenue Growth 23STAAR Surgical Reports 10% Second Quarter Revenue Growth 24STAAR Surgical Reports 10% Second Quarter Revenue Growth 25STAAR Surgical Reports 10% Second Quarter Revenue Growth 26STAAR Surgical Reports 10% Second Quarter Revenue Growth 27STAAR Surgical Reports 10% Second Quarter Revenue Growth 28STAAR Surgical Reports 10% Second Quarter Revenue Growth 29STAAR Surgical Reports 10% Second Quarter Revenue Growth 30STAAR Surgical Reports 10% Second Quarter Revenue Growth 31Pharmacyclics Reports Second Quarter 2014 Results 2Pharmacyclics Reports Second Quarter 2014 Results 3Pharmacyclics Reports Second Quarter 2014 Results 4Pharmacyclics Reports Second Quarter 2014 Results 5Pharmacyclics Reports Second Quarter 2014 Results 6
... SANTA BARBARA, Calif., Dec. 6, 2010 Direct ... has donated critically needed medical supplies to assist cholera ... University Hospital (JUH) in Cap-Haitien. JUH is the main public ... I.V. solutions and supplies will also be distributed to the ...
... DIEGO, Dec. 6, 2010 /PRNewswire/ -- Cylene Pharmaceuticals, ... of their first-in-class CK2 inhibitor at the 52nd Annual Meeting ... on December 4-7 in Orlando, FL, the company announced today. ... on targeting CK2, a protein kinase that is essential for ...
Cached Medicine Technology:CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti 2CSL Behring Medical Product Donation Helps Meet Critical Need for Ongoing Cholera Relief Effort in Haiti 3Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting 2Cylene Selected to Present CK2 Inhibitor Multiple Myeloma Data at American Society of Hematology Meeting 3
Lab-Reader...
Fully automatic NRTL and CE certified microplate reader....
The Benchmark Microplate Reader, with its increased wavelength range of 340 to 750 nm and high performance optics, provides flexibility for specialized applications requiring increased linearity, ult...
EL301 Microwell Strip Reader is a portable, rugged, single/dual wavelength photometer designed to measure and interpret the absorbances of microwell strip assays....
Medicine Products: